Research News
A team led by Cedars-Sinai Health Sciences University investigators has identified a protein that may hide aging cells from the body’s immune system, allowing them to build up and contribute to age-related health …
Investigators at Cedars-Sinai Health Sciences University used an experimental drug to reverse the effects of systemic sclerosis, a serious autoimmune disease. The study, conducted in a laboratory, was published in …
A new study led by Cedars-Sinai Health Sciences University investigators found that prostate-specific antigen (PSA) levels in the blood, which are used …
When added to standard chemotherapy, a clinical version of the dietary supplement L-glutamine improved survival in an early-phase trial of patients with advanced pancreatic cancer. The study, led by Cedars-Sinai Health Sciences University …
Donations to Cedars-Sinai surpassed $200 million at the close of fiscal year 2026, a milestone now reached only three times in the medical center’s 124-year history. Grateful patients donated most of the gifts.
During FY 2026, which ended …
Brain cells that release dopamine—a messenger chemical that drives motor control— package it into tiny membrane-bound sacs called synaptic vesicles. And these …
Cedars-Sinai Health Sciences University investigators have identified a protein that helps repair damage to the bone marrow after chemotherapy and radiation.
The protein restores the blood stem cell niche—the specialized environment that …
Women who test negative for BRCA gene mutations may still be at greater risk of developing breast cancer than the general population, according to a study led by Cedars-Sinai Health Sciences University investigators. The findings, published in …
Two studies from investigators at Cedars-Sinai Health Sciences University move the medical field closer to solving a longstanding challenge: predicting who is at risk for sudden cardiac …